Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the efficacy and safety of a routine individualized antiplatelet therapy after coronary stent implantation by evaluating "on-treatment" platelet reactivity with Multiple Electrode Aggregometry (MEA, Multiplate® Analyzer).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kaiser Franz Josef Hospital
• Treatments: Clopidogrel; Prasugrel Hydrochloride; Ticagrelor; Ticlopidine

Criteria

Inclusion Criteria:

• all consecutive PCI patients with stent implantation of our institution

Exclusion Criteria:

• pregnancy